Digital Health Outcomes Blog

Value communication in Pharma

Value communication in pharma
Oleksandr Topachevskyi
May 9, 2023
4 min.
0

Today, many companies, including those in the healthcare industry, believe that the customer, not the competition, drives success. An increased focus on the customer leads manufacturers and healthcare providers to the notion of value, which is especially… Read more

What is Real World Evidence (RWE) in pharma

Real World Evidence
Oleksandr Topachevskyi
March 23, 2023
6 min.
0

The aim of real-world evidence, or RWE, is to improve healthcare decision-making by complementing data generated from randomized controlled trials (RCTs). While RCTs come in handy to investigate the question ‘Can this health technology work?’, RWE… Read more

Systematic Review and Meta-Analysis — Overview 

Systematic review-and meta analysis main pic
Oleksandr Topachevskyi
March 15, 2023
6 min.
0

Meta-analysis and systematic review are at the top of the hierarchy of evidence for data reliability in various types of biomedical research. They are an integral part of evidence-based medicine. Most clinicians begin searching for the best, evidence-based… Read more

Payer Value Proposition in Pharma

Payer Value Proposition in Pharma
Oleksandr Topachevskyi
February 10, 2023
5 min.
0

Launching a new product in the field of biopharma is a challenge not only for a drug manufacturer, that is pharmaceutical company, but also for marketers working to demonstrate the value. The reason is quite simple:… Read more

What do you need to know about Health Economics Outcomes Research (HEOR). Definitions and Examples

heor-model-modern-app
Oleksandr Topachevskyi
February 8, 2023
7 min.
0

HEOR – term and job position/function used in the pharmaceutical industry.  It is also an emerging field of research in health economics that focuses on providing pharmaceutical and life sciences companies with evidence of the value… Read more

Cost-Effectiveness Analysis VS Cost-Benefit Analysis

Cost-effectiveness analysis VS cost-benefit analysis
Oleksandr Topachevskyi
January 19, 2023
3 min.
0

Before investing in a pharmaceutical product or a medical device company, a payer must evaluate the economic value of the proposed intervention. Hence, it’s important to understand modelling methods used to demonstrate the value and the… Read more

What is Patient Engagement in Healthcare and Why is it Important

Patient Engagement in Healthcare
Oleksandr Topachevskyi
January 9, 2023
5 min.
0

Many people are inattentive to their health. Drinking alcohol, smoking, and lack of time for sports. By the age of 50, many chronic diseases appear. Patient engagement apps can help to avoid these health related issues by collecting… Read more

Running Machine Learning Models and Predictions on the Web

Running Machine Learning Models
Oleksandr Topachevskyi
November 3, 2022
2 min.
0

The year 2022 started difficult here in Ukraine, although there are positive news and developments with new partners. We were approached by TriNetX Oncology GmbH (Freiburg im Breisgau, Germany) and CancerDataNet GmbH (Basel, Switzerland) with the… Read more

Markov model for cost-effectiveness analysis

Oleksandr Topachevskyi
September 17, 2022
6 min.
0

The Markov model in pharmacoeconomics is used to simulate clinical and economic effects of treatments, compare healthcare programs and aid decision making. What is the Markov model? The Markov model is a mathematical model involving a… Read more

Why automatic (machine) translation may be a useful feature for content localization

Machine translation
Oleksandr Topachevskyi
September 9, 2022
6 min.
0

Most users and content creators who have ever used automated translation tools and API’s like Google, DeepL, Bing, Amazon Translators and some advanced artificial intelligence translation software, know that even though the technology is constantly being… Read more

1 2 3 4